Cariporide
Cariporide is a selective sodium-hydrogen antiporter 1 (NHE-1) inhibitor that was developed by Sanofi-Aventis. It is primarily used in the treatment of ischemic heart disease, specifically to reduce the risk of myocardial infarction (heart attack).
Mechanism of Action[edit | edit source]
Cariporide works by inhibiting the NHE-1 antiporter, a protein that regulates the balance of sodium and hydrogen ions in cells. This inhibition reduces the amount of sodium and calcium that enters the cell during ischemic conditions, which can help to prevent cell death and reduce the size of a myocardial infarction.
Clinical Trials[edit | edit source]
Cariporide has been studied in several large-scale clinical trials. The most notable of these was the Guardian trial, which evaluated the efficacy of cariporide in reducing the risk of death and myocardial infarction in patients undergoing coronary artery bypass graft (CABG) surgery. The results of this trial were promising, but the drug has not yet been approved for this use by the Food and Drug Administration (FDA).
Side Effects[edit | edit source]
Like all medications, cariporide can cause side effects. The most common side effects reported in clinical trials include nausea, vomiting, and hypotension (low blood pressure). In rare cases, cariporide can cause serious side effects such as arrhythmia (irregular heartbeat) and hyperkalemia (high potassium levels in the blood).
Future Research[edit | edit source]
While cariporide is not currently approved for use in the United States, research into its potential benefits continues. Future studies may focus on its potential use in other conditions, such as stroke and chronic heart failure.
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
 | This cardiovascular system article is a stub. You can help WikiMD by expanding it. |
This pharmacology related article is a stub. You can help WikiMD by expanding it.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
